Topics

Companies Related to "arms race between bacteria their phage foes" [Most Relevant Company Matches] RSS

18:50 EST 19th February 2020 | BioPortfolio

Here are the most relevant search results for "arms race between bacteria their phage foes" found in our extensive corporate database of over 50,000 company records.

Showing "arms race between bacteria their phage foes" Companies 1–25 of 267

Extremely Relevant

BiomX Inc.

BiomX is a clinical stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC, and cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.


Relevant

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II many dreaded infectious diseases such as diphtheria, pneumonia, syphilis, and tuberculosis disappeared almost overnight. However all is not well with the antibiotics story. The bacterial pathogens are f...

Adaptive Phage Therapeutics (APT)

Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. APT leverages the world’s largest therapeutic phage library (PhageBank®) with a companion diagnostic to achieve rapid response and cost-effective therapy for o...


Pennsylvania Environmental Council

Covering a total distance of 20-30 miles in four to six hours, on foot and on bike, the Oyster Race is the ultimate urban adventure race taking teams of three to six people through a top secret, high-adrenaline course in a race around the city. Want to scavenger around the zoo, blind taste test beers at the pub, or zip down a slip ‘n slide in your nex...

Adaptive Phage Therapeutics, Inc. (APT)

Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. APT’s core asset is a large and continually expanding phage library (PhageBankTM) deployed with a companion diagnostic to achieve rapid response and cost-effective therapy for otherwise recalcitrant bact...

Spartan Race

Spartan Race is an international obstacle racing series with three levels of courses: three-mile Sprints with 10 obstacles; eight-mile Olympic (Supers) with 15 obstacles; and 10- to 12-mile Ultras (Beast). Death Race is the annual, grand-finale event. Racers may compete as individuals or teams. The series is the brainchild of Joe Desena of Pittsfield, Vt.,...

ARMS Medical

ARMS Medical provides advanced surgical technologies and tools for pelvic floor issues, including organ prolapse and incontinence. Our goal is to help patients, surgeons and hospitals by optimizing outcomes, maximizing safety and minimizing complications. ARMS Medical supplies a suite of products to the healthcare industry, including DermaPure allograft, S...

Transgalactic Limited

A microbiology reader runs microbiology tests automatically, simultaneously monitoring the growth of microorganisms in 200 wells. Corresponding growth curves and microbiological calculations are shown in MS Excel. Any experiment where the growth of bacteria, yeast, fungi, cell or phage are to be followed kinetically in a liquid growth medium can be performed.

Reebok Spartan Race

Reebok Spartan Race, voted Outside Magazine’s Best Obstacle Race in 2012, is the world’s leading obstacle racing series and the first of its kind to have global rankings. With 350,000 participants in 2012 and 60 events planned for 2013, Reebok Spartan Race is making this one of the fastest growing sports in the world. Reebok Spartan Race is a timed ...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to combat the increasing number of antibiotic-resistant infections worldwide. The Company has two short-term strategic objectives:To identify and formulate proprietary topical Phage preparations from dis...

Better Series

Best known for being the Oregon-based race event management company that brought Hood to Coast Relay to the masses, the Better Series now consists of seven running and one cycling events. The race series stretches from May through November, and features well-known events such as Hippie Chick Quarter & Half Marathon Run & Walk; Reach the Beach; Helvetia Hal...

RAM Racing

RAM Racing is the nation’s premier race production company, known for producing race parties of the highest quality resulting in an unforgettable emotional experience from start to finish. CEO and founder Steve Ginsburg started RAM Racing to make the racing experience bigger and better than it ever was, and his company is synonymous with top of the li...

USA Pro Cycling Challenge

For seven consecutive days, the world’s top athletes race through the majestic Rockies, reaching higher altitudes than they’ve ever had to endure – more than two miles in elevation. One of the largest cycling events in United States history, the 2012 race will feature the best of the best in professional cycling, competing on a challenging course ...

ConjuGon

The rise of drug-resistant strains of pathogenic bacteria is quickly becoming a health problem of potentially crisis proportions. Virtually all experts agree that entirely new approaches are needed to go beyond the use of traditional antibiotics. Fundamentally new, even radical, anti-microbial agents are necessary to kill pathogenic bacteria while minimizing the ability of the bacteria to develop ...

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with research and development laboratories in Kiev, Ukraine. Currently Phage has approximately 75 employees worldwide. The Company was initially formed to manufacture recombinant protein pharmaceuticals as “ge...

GBS/CIDP Foundation

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser ext...

Vincogen Corporation

Vincogen Corporation is a RF ID Biochip company established in year 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms for use in several applications across the diagnostic and pharmaceutical industries. In order to achieve the goal of Personalized Medicine, we are co-developing RFID chip (semi-conductor part) and T4 phage display (Bio part)...

Open Arms

Lysando AG

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial designer proteins with a team of scientists in the town of Regensburg. Artilysin®s represent a revolutionary breakthrough in the battle against multi-resistant bacteria. With this ...

Adaptive Phage Therapeutics, Inc.

Adaptive Phage Therapeutics, Inc.

Mercator Therapeutics, Inc.

Mercator Therapeutics is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. Mercator was founded to translate the research of Drs. Wadih Arap and Renata Pasqualini into effective cancer therapeutics. Drs. Arap and Pasqualini pioneered the use of in vivo phage display to identify peptide...

Phage Pharmaceuticals, Inc.

Pepscan Therapeutics BV

Mercator Therapeutics is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. Mercator was founded to translate the research of Drs. Wadih Arap and Renata Pasqualini into effective cancer therapeutics. Drs. Arap and Pasqualini pioneered the use of in vivo phage display to identify peptides that are believed to selectively del...

Enterologics, Inc.

Enterologics, Inc. (OTCBB: ELGO.OB) is a biotechnology company that is developing probiotics as biologic drugs for specific gastrointestinal disease indications. Probiotics are live microorganisms, in most cases, bacteria, that are similar to or derived from beneficial microorganisms that are found in the human gut (e.g. for more information see Introducti...


More From BioPortfolio on "arms race between bacteria their phage foes"

Quick Search

Corporate Database Quicklinks